Xanthic Biopharma Inc. Announces Official Filing of Patents to Protect Company’s Proprietary Manufacturing Process and Products
pharmaceutical investing Cyclacel Announces Notice of Grant of New European Patent Covering Sapacitabine Pharmaceutical Formulations
Patent Coverage for TNG's Proprietary Tivan Process for Extraction of Vanadium Extended to USA and Russia
Alvopetro Announces Q3 2026 Dividend of US$0.12 Per Share and Supplementary Information on December 31, 2025 Prospective Resources
Skyharbour Partner Company Purecore Commences Data Compilation and Target Generation at The Yurchison Uranium Property
